Guggenheim Lowers MacroGenics (NASDAQ:MGNX) to Neutral

Guggenheim lowered shares of MacroGenics (NASDAQ:MGNX – Free Report) from a buy rating to a neutral rating in a research note released on Wednesday morning, Marketbeat Ratings reports. A number of other research firms have also recently issued reports on MGNX. B. Riley started coverage on MacroGenics in a report on Friday, April 26th. They […]

Leave a Reply

Your email address will not be published.

Previous post Park City Group (NASDAQ:PCYG) Coverage Initiated by Analysts at StockNews.com
Next post Steven Madden’s (SHOO) Market Perform Rating Reiterated at Telsey Advisory Group